Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-Analysis of Randomized Controlled Trials
Background: Shensong Yangxin capsule (SSYX) is a well-known traditional Chinese patent medicine for treating arrhythmia. Recently, a flurry of randomized controlled trials (RCTs) of SSYX combined with amiodarone (SSYX-amiodarone) was reported in the treatment of heart failure (HF) complicated by ven...
Saved in:
Main Authors: | Xinfu Cao (Author), Mingxue Zhou (Author), Hongxu Liu (Author), Xiufen Chen (Author), Xiang Li (Author), Sihan Jia (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling
by: Hong-Jie Yang, et al.
Published: (2020) -
Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction
by: Zhang J, et al.
Published: (2023) -
Clinical efficacy and safety of Shensong Yangxin capsule combined with metoprolol for treating cardiac arrhythmia: A meta-analysis of randomized controlled trials
by: Xinrui Wang, et al.
Published: (2023) -
Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
by: Ma J, et al.
Published: (2018) -
Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure
by: Tohru Ujihira, et al.
Published: (2011)